Skip to contentSwirsky Douglas J — GENVEC INC insider: 83 transactions · InsiderLensSwirsky Douglas J
- CHIEF FINANCIAL OFFICER at MAXCYTE, INC. · on record since Mar 28, 2023
- Director at POLYMEDIX INC · on record since Jul 6, 2009
- Principal Accounting Officer at Barinthus Biotherapeutics plc. · on record since May 1, 2026
- Director at ISOLAGEN INC · on record since Mar 5, 2013
- Director at GENVEC INC · on record since Sep 5, 2013
- President and CEO at GENVEC INC · on record since Jun 20, 2017
- Director at Cellectar Biosciences, Inc. · on record since Apr 18, 2017
- Director at GOLF TRUST OF AMERICA INC · on record since Nov 17, 2017
- Director at REXAHN PHARMACEUTICALS, INC. · on record since Nov 16, 2018
- President and CEO at REXAHN PHARMACEUTICALS, INC. · on record since Nov 16, 2018
- Director at MetaVia Inc. · on record since Sep 3, 2020
Insider trading activity of Swirsky Douglas J
- Transactions on record
- 83
- since Sep 19, 2006
- Open-market buys
- 24
- $236.1K
- Open-market sells
- 2
- $30.4K
- Companies traded
- 8
- last filing Mar 19, 2026
Figures computed from official regulatory filings — methodology.
Companies where Swirsky Douglas J has traded
- MAXCYTE, INC.8 tx · $94.9K · Mar 19, 2026
- Cellectar Biosciences, Inc.10 tx · $26K · Feb 18, 2025
- MetaVia Inc.1 tx · Sep 3, 2020
- ISOLAGEN INC16 tx · Dec 13, 2019
- REXAHN PHARMACEUTICALS, INC.3 tx · $31.5K · Jan 30, 2019
- GOLF TRUST OF AMERICA INC2 tx · May 23, 2018
- GENVEC INC39 tx · $544.6K · Jun 20, 2017
- POLYMEDIX INC4 tx · Mar 28, 2012
Track record of Swirsky Douglas J
Statistical track record
Free- Open-market buys
- 24
- Last buy
- Aug 13, 2025
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Swirsky Douglas J
Co-insiders of Swirsky Douglas J
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
AEI Fund Management XXI, IncPOLYMEDIX INC
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Mar 19, 2026 | Sell | -10,142 | 0.82 USD | $8.3K | SEC |
| Aug 13, 2025 | Buy | 50,000 | 1.29 USD | $64.5K | SEC |
| Mar 20, 2025 | Sell | -6,939 | 3.18 USD | $22.1K | SEC |
| Mar 18, 2025 | Award | 37,500 | 0.00 USD | $0 | SEC |
| Mar 18, 2025 | AwardD | 150,000 | 0.00 USD | $0 | SEC |
| Feb 18, 2025 | AwardD | 90,000 | 0.00 USD | $0 | SEC |
| Jun 18, 2024 | AwardD | 90,000 | 0.00 USD | $0 | SEC |
| Mar 19, 2024 | AwardD | 225,000 | 0.00 USD | $0 | SEC |
| Mar 19, 2024 | Award | 81,250 | 0.00 USD | $0 | SEC |
| Jun 28, 2023 | AwardD | 37,500 | 0.00 USD | $0 | SEC |
| Mar 28, 2023 | AwardD | 350,000 | 0.00 USD | $0 | SEC |
| Aug 1, 2022 | AwardD | 11,700 | 0.00 USD | $0 | SEC |
| Sep 14, 2021 | Buy | 25,000 | 1.04 USD | $26K | SEC |
| Jul 2, 2021 | AwardD | 117,000 | 0.00 USD | $0 | SEC |
| Sep 3, 2020 | AwardD | 60,000 | 0.00 USD | $0 | SEC |
| Jun 25, 2020 | AwardD | 80,000 | 0.00 USD | $0 | SEC |
| Dec 13, 2019 | OtherD | -6,000 | — | — | SEC |
| Dec 13, 2019 | OtherD | -2,400 | — | — | SEC |
| Dec 13, 2019 | OtherD | -2,400 | — | — | SEC |
| Dec 13, 2019 | OtherD | -12,000 | — | — | SEC |
| Dec 13, 2019 | OtherD | -534 | — | — | SEC |
| Dec 13, 2019 | OtherD | -1,200 | — | — | SEC |
| Dec 13, 2019 | OtherD | -6,000 | — | — | SEC |
| Dec 13, 2019 | OtherD | -1,600 | — | — | SEC |
| Jun 14, 2019 | AwardD | 12,000 | — | — | SEC |